In the last trading session, 7.93 million shares of the Bristol-Myers Squibb Co. (NYSE:BMY) were traded, and its beta was 0.42. Most recently the company’s
Bristol-Myers Squibb Co. (NYSE:BMY)’s traded shares stood at 10.91 million during the last session, with the company’s beta value hitting 0.42. At the close of
In the last trading session, 11.91 million Bristol-Myers Squibb Co. (NYSE:BMY) shares changed hands as the company’s beta touched 0.41. With the company’s per share
In last trading session, Bristol-Myers Squibb Co. (NYSE:BMY) saw 11.77 million shares changing hands with its beta currently measuring 0.40. Company’s recent per share price
Bristol-Myers Squibb Co. (NYSE:BMY) has a beta value of 0.40 and has seen 12.25 million shares traded in the last trading session. The company, currently
During the last session, Bristol-Myers Squibb Co. (NYSE:BMY)’s traded shares were 10.98 million, with the beta value of the company hitting 0.39. At the end
In the last trading session, 9.51 million shares of the Bristol-Myers Squibb Co. (NYSE:BMY) were traded, and its beta was 0.38. Most recently the company’s
In the last trading session, 9.76 million Bristol-Myers Squibb Co. (NYSE:BMY) shares changed hands as the company’s beta touched 0.38. With the company’s per share
In recent trading session, Bristol-Myers Squibb Co. (NYSE:BMY) saw 1.82 million shares changing hands at last check today with its beta currently measuring 0.38. Company’s
Bristol-Myers Squibb Co. (NYSE:BMY) has a beta value of 0.37 and has seen 19.73 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
